![Nelson Chao](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Nelson Chao
Presidente en American Society for Blood & Marrow Transplantation .
Perfil
Nelson Chao is the founder of Aldagen, Inc., which was founded in 2000.
He held the title of Secretary from 2009 to 2012.
Currently, he holds the title of Principal at Duke University Medical Center and the title of President at American Society for Blood & Marrow Transplantation.
Cargos activos de Nelson Chao
Empresas | Cargo | Inicio |
---|---|---|
Duke University Medical Center | Corporate Officer/Principal | - |
American Society for Blood & Marrow Transplantation | Presidente | - |
Antiguos cargos conocidos de Nelson Chao.
Empresas | Cargo | Fin |
---|---|---|
Aldagen, Inc.
![]() Aldagen, Inc. Pharmaceuticals: GenericHealth Technology Aldagen, Inc. develops and produces pharmaceutical products. It focuses on developing product candidates to address cardiovascular disease. The firm develops ALD-301 for the treatment of critical limb ischemia; ALD-201 for the treatment of ischemic heart failure; and ALD-401 for the post-acute treatment of ischemic stroke. The company also supplies ALDHbr cells for use in investigator-sponsored clinical studies. Aldagen was founded by Andrew E. Balber, Michael Sherman Colvin, Clay Smith and Nelson Chao in March 2000 and is headquartered in Durham, NC. | Fundador | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 2 |
---|---|
Aldagen, Inc.
![]() Aldagen, Inc. Pharmaceuticals: GenericHealth Technology Aldagen, Inc. develops and produces pharmaceutical products. It focuses on developing product candidates to address cardiovascular disease. The firm develops ALD-301 for the treatment of critical limb ischemia; ALD-201 for the treatment of ischemic heart failure; and ALD-401 for the post-acute treatment of ischemic stroke. The company also supplies ALDHbr cells for use in investigator-sponsored clinical studies. Aldagen was founded by Andrew E. Balber, Michael Sherman Colvin, Clay Smith and Nelson Chao in March 2000 and is headquartered in Durham, NC. | Health Technology |
American Society for Blood & Marrow Transplantation |
- Bolsa de valores
- Insiders
- Nelson Chao